Can-Fite BioPharma Ltd.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $5.7M | $8.2M | $2.7M |
| FY2020 | $3.4M | $9.5M | $8.3M |
| FY2021 | $5.9M | $20.3M | $4.4M |
| FY2022 | $4.8M | $9.3M | $3.0M |
| FY2023 | $3.7M | $10.0M | $4.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $5.7M | $8.2M | $2.7M |
| FY2020 | $3.4M | $9.5M | $8.3M |
| FY2021 | $5.9M | $20.3M | $4.4M |
| FY2022 | $4.8M | $9.3M | $3.0M |
| FY2023 | $3.7M | $10.0M | $4.3M |